Internal and Emergency Medicine

, Volume 14, Issue 1, pp 11–15 | Cite as

Atrial fibrillation in organ transplant recipients: only a marker of the underlying disease?

  • Francesca InnocentiEmail author
  • Riccardo Pini

Despite good progress in the management of patients with atrial fibrillation (AF), this dysrhythmia remains one of the major causes of cardiovascular morbidity and mortality in the world [1, 2, 3, 4, 5]. In the general population, the number of patients with AF is predicted to rise steeply in the coming years: the increase in AF prevalence can be attributed both to better detection of silent AF alongside increasing age and conditions predisposing to it [6, 7, 8]. But AF is not just a problem of the general population: in the critically ill, this dysrhythmia is gaining increasing attention, because it represents a frequent complication (reported incidence from 5 to 15% in different studies), and its presence is associated with an increased mortality, as well as with a longer stay in the Intensive Care Unit [9]. Risk factors include advanced age, white race, high severity scores, presence of organ failures and sepsis. This situation underlines the need to prevent and treat patients with...


Compliance with ethical standards

Conflict of interest

The authors have no conflict of interest to declare.

Statement of human and animal rights

The study protocol was approved by the local Ethics Committee.

Informed consent

All subjects provided oral and written informed consent.


  1. 1.
    Andersson T, Magnuson A, Bryngelsson IL et al (2013) All-cause mortality in 272,186 patients hospitalized with incident atrial fibrillation 1995–2008: a Swedish nationwide long-term case–control study. Eur Heart J 34:1061–1067CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Stewart S, Hart CL, Hole DJ, McMurray JJ (2002) A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the renfrew/paisley study. Am J Med 113:359–364CrossRefPubMedGoogle Scholar
  3. 3.
    Prisco D, Cenci C, Silvestri E, Emmi G, Barnini T, Tamburini C (2012) The risk stratification in atrial fibrillation. Intern Emerg Med 7:S233–S240CrossRefPubMedGoogle Scholar
  4. 4.
    Raparelli V, Pastori D, Pignataro SF et al (2018) Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study. Intern Emerg Med 13:651–660CrossRefPubMedGoogle Scholar
  5. 5.
    Pastori D, Farcomeni A, Poli D et al (2016) Cardiovascular risk stratification in patients with non-valvular atrial fibrillation: the 2MACE score. Intern Emerg Med 11:199–204CrossRefPubMedGoogle Scholar
  6. 6.
    Sanna T, Diener HC, Passman RS et al (2014) Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med 370:2478–2486CrossRefPubMedGoogle Scholar
  7. 7.
    Wang TJ, Larson MG, Levy D et al (2003) Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the framingham heart study. Circulation 107:2920–2925CrossRefPubMedGoogle Scholar
  8. 8.
    Salvatori V, Becattini C, Laureti S et al (2015) Holter monitoring to detect silent atrial fibrillation in high-risk subjects: the perugia general practitioner study. Intern Emerg Med 10:595–601CrossRefPubMedGoogle Scholar
  9. 9.
    Yoshida T, Fujii T, Uchino S, Takinami M (2015) Epidemiology, prevention, and treatment of new-onset atrial fibrillation in critically ill: a systematic review. J Intensive Care 3:19CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Hu WS, Lin CL (2018) Risk of new-onset atrial fibrillation among heart, kidney and liver transplant recipients: insights from a national cohort study. Intern Emerg Med. CrossRefPubMedGoogle Scholar
  11. 11.
    Andersson T, Magnuson A, Bryngelsson IL et al (2014) Gender-related differences in risk of cardiovascular morbidity and all-cause mortality in patients hospitalized with incident atrial fibrillation without concomitant diseases: a nationwide cohort study of 9519 patients. Int J Cardiol 177:91–99CrossRefPubMedGoogle Scholar
  12. 12.
    Ko D, Rahman F, Schnabel RB, Yin X, Benjamin EJ, Christophersen IE (2016) Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis. Nat Rev Cardiol 13:321–332CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Nguyen TN, Hilmer SN, Cumming RG (2013) Review of epidemiology and management of atrial fibrillation in developing countries. Int J Cardiol 167:2412–2420CrossRefPubMedGoogle Scholar
  14. 14.
    Oldgren J, Healey JS, Ezekowitz M et al (2014) Variations in cause and management of atrial fibrillation in a prospective registry of 15,400 emergency department patients in 46 countries: the RE-LY atrial fibrillation registry. Circulation 129:1568–1576CrossRefPubMedGoogle Scholar
  15. 15.
    Xia VW, Worapot A, Huang S et al (2015) Postoperative atrial fibrillation in liver transplantation. Am J Transplant 15:687–694CrossRefPubMedGoogle Scholar
  16. 16.
    La Manna G, Boriani G, Capelli I et al (2013) Incidence and predictors of postoperative atrial fibrillation in kidney transplant recipients. Transplantation 96:981–986CrossRefPubMedGoogle Scholar
  17. 17.
    Amar D (2004) Strategies for perioperative arrhythmias. Best Pract Res Clin Anaesthesiol 18:565–577CrossRefPubMedGoogle Scholar
  18. 18.
    Lentine KL, Schnitzler MA, Abbott KC et al (2006) Incidence, predictors, and associated outcomes of atrial fibrillation after kidney transplantation. Clin J Am Soc Nephrol 1:288–296CrossRefPubMedGoogle Scholar
  19. 19.
    Abbott KC, Reynolds JC, Taylor AJ, Agodoa LY (2003) Hospitalized atrial fibrillation after renal transplantation in the United States. Am J Transplant 3:471–476CrossRefPubMedGoogle Scholar
  20. 20.
    Alonso A, Misialek JR, Amiin MA et al (2014) Circulating levels of liver enzymes and incidence of atrial fibrillation: the Atherosclerosis risk in communities cohort. Heart 100:1511–1516CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Ahmari SA, Bunch TJ, Chandra A et al (2006) Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter. J Heart Lung Transplant 25:53–60CrossRefPubMedGoogle Scholar
  22. 22.
    Dasari TW, Pavlovic-Surjancev B, Patel N et al (2010) Incidence, risk factors, and clinical outcomes of atrial fibrillation and atrial flutter after heart transplantation. Am J Cardiol 106:737–741CrossRefPubMedGoogle Scholar

Copyright information

© Società Italiana di Medicina Interna 2018

Authors and Affiliations

  1. 1.High-Dependency Unit, Department of Clinical and Experimental MedicineAzienda Ospedaliero-Universitaria CareggiFlorenceItaly

Personalised recommendations